Home |  English version |  Mappa |  Commenti |  Sondaggio |  Staff |  Contattaci Cerca nel sito  
Istituto di scienza dell'alimentazione

Torna all'elenco Contributi in rivista anno 2010

Contributo in rivista

Tipo: Articolo in rivista

Titolo: Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients.

Anno di pubblicazione: 2010

Formato: Elettronico Cartaceo

Autori: Annuzzi G; Piscitelli F; Di Marino L; Patti L; Giacco R; Costabile G; Bozzetto L; Riccardi G; Verde R; Petrosino S; Rivellese AA; Di Marzo V.

Affiliazioni autori: Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy Endocannabinoid Research Group, Institute of Biomolecular Chemistry, CNR, Pozzuoli Naples, Italy National Research Council, Avellino, Italy

Autori CNR:

  • VINCENZO DI MARZO
  • ROSALBA GIACCO
  • STEFANIA PETROSINO
  • FABIANA PISCITELLI
  • GABRIELE RICCARDI

Abstract: Abstract: Background: The endocannabinoids, anandamide and 2-AG, are produced by adipocytes, where they stimulate lipogenesis via cannabinoid CB(1) receptors and are under the negative control of leptin and insulin. Endocannabinoid levels are elevated in the blood of obese individuals and nonobese type 2 diabetes patients. To date, no study has evaluated endocannabinoid levels in subcutaneous adipose tissue (SAT) of subjects with both obesity and type 2 diabetes (OBT2D), characterised by similar adiposity and whole body insulin resistance and lower plasma leptin levels as compared to non-diabetic obese subjects (OB). Design and Methods: The levels of anandamide and 2-AG, and of the anandamide-related PPAR alpha ligands, oleoylethanolamide (OEA) and palmitoylethanolamide (PEA), in the SAT obtained by abdominal needle biopsy in 10 OBT2D, 11 OB, and 8 non-diabetic normal-weight (NW) subjects, were measured by liquid chromatography-mass spectrometry. All subjects underwent a hyperinsulinaemic euglycaemic clamp. Results: As compared to NW, anandamide, OEA and PEA levels in the SAT were 2-4.4-fold elevated (p < 0.05), and 2-AG levels 2.3-fold reduced (p <.05), in OBT2D but not in OB subjects. Anandamide, OEA and PEA correlated positively (p <.05) with SAT leptin mRNA and free fatty acid during hyperinsulinaemic clamp, and negatively with SAT LPL activity and plasma HDL-cholesterol, which were all specifically altered in OBT2D subjects. Conclusions: The observed alterations emphasize, for the first time in humans, the potential different role and regulation of adipose tissue anandamide (and its congeners) and 2-AG in obesity and type 2 diabetes.

Lingua abstract: inglese

Pagine da: 43

Pagine totali: 8

Rivista:

Lipids in health and disease BioMed Central,
Paese di pubblicazione: Regno Unito
Lingua: inglese
ISSN: 1476-511X

Numero volume: 9

DOI: 10.1186/1476-511X-9-43

Referee: Sì: Internazionale

Indicizzato da:

  • ISI Web of Science (WOS) [000277514000001]
  • PubMed [20426869]

Parole chiave:

  • Endocannabinoids
  • Adipose tissue
  • Type 2 diabete
  • Obese subjects

Strutture CNR:

Moduli:

 
Torna indietro Richiedi modifiche Invia per email Stampa
Home Il CNR  |  I servizi News |   Eventi | Istituti |  Focus